Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
19
BTAI Quote, Financials, Valuation and Earnings
Last price:
$1.52
Seasonality move
:
-27.12%
Day range:
$1.31 - $1.44
52-week range:
$1.17 - $27.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.41x
P/B ratio:
--
Volume:
226.3K
Avg. volume:
304.5K
1-year change:
-94.93%
Market cap:
$8.3M
Revenue:
$2.3M
EPS (TTM):
-$13.55
BioXcel Therapeutics Number of Institutional Trades
BioXcel Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$90.7M
(Last 6 Months)
Current Institutional Ownership Percentage
6.02%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$444.2M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BioXcel Therapeutics Institutional Ownership
-
What Percentage Of BTAI Is Owned by Institutions?
6.02% of BTAI is owned by institutions.
-
How Many Institutions Own BTAI Shares?
BioXcel Therapeutics stock is owned by 106 institutional shareholders at this time.
-
Have Institutions Been Buying BTAI Stock?
Yes, institutions have bought 758.7K shares of BTAI in the last quarter.
-
Have Institutions Been Selling BTAI Stock?
Yes, institutions have sold 34.7M shares of BTAI over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
